Effect of aripiprazole on promoting cognitive function and enhancing clinical efficacy in patients with first-episode depression on escitalopram: A randomized …
Y Wang, Z Lu, G Xun - Journal of Affective Disorders, 2024 - Elsevier
Objectives To explore the effect of escitalopram combined with aripiprazole on cognitive
function in patients with major depressive disorder (MDD), and to evaluate the clinical …
function in patients with major depressive disorder (MDD), and to evaluate the clinical …
Pretreatment anxious depression as a predictor of side effect frequency and severity in escitalopram and aripiprazole adjunctive therapy
CW Espinola, Y Khoo, R Parmar… - Brain and …, 2022 - Wiley Online Library
Objective To report side effect frequency and severity in patients with major depressive
disorder (MDD) receiving escitalopram and aripiprazole adjunctive therapy and to examine …
disorder (MDD) receiving escitalopram and aripiprazole adjunctive therapy and to examine …
Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
G Wang, X You, X Wang, X Xu, L Bai, J Xie… - Neuropsychiatric …, 2018 - Taylor & Francis
Background Anxiety symptoms usually worsen depression and functional impairment. The
present study was aimed to evaluate the impact of escitalopram on social function and …
present study was aimed to evaluate the impact of escitalopram on social function and …
A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine
Z Li, TT Wu, YT Xiong, XY Zhang, YP Bao… - Frontiers in …, 2023 - frontiersin.org
Objective This study aimed to explore both impairments in attention function in patients with
major depressive disorder (MDD) and the efficacy of escitalopram monotherapy or …
major depressive disorder (MDD) and the efficacy of escitalopram monotherapy or …
Impacts on quality of life with escitalopram monotherapy and aripiprazole augmentation in patients with major depressive disorder: A CAN-BIND report
E Morton, V Bhat, P Giacobbe, W Lou… - …, 2021 - thieme-connect.com
Introduction Many individuals with major depressive disorder (MDD) do not respond to initial
antidepressant monotherapy. Adjunctive aripiprazole is recommended for treatment non …
antidepressant monotherapy. Adjunctive aripiprazole is recommended for treatment non …
Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical …
HJ Kim, DH Han, KT Choi, HC Hwang… - Journal of …, 2023 - journals.sagepub.com
Background: Somatic symptoms, which are common in major depressive disorder (MDD),
are associated with a worse prognosis and increased health costs. Aims: This randomized …
are associated with a worse prognosis and increased health costs. Aims: This randomized …
Early-Onset Effectiveness of Adjunctive Aripiprazole in Patients With Depression With Inadequate Response to First-Line Antidepressants
Y Lee, EY Kim, HJ Lee, SJ Rhee, SJ Cho… - Psychiatric …, 2022 - journals.healio.com
The aim of this study was to investigate the early effectiveness of adjunctive aripiprazole
treatment on the clinical symptoms and quality of life in patients with major depressive …
treatment on the clinical symptoms and quality of life in patients with major depressive …
Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese …
K Jiang, L Li, X Wang, M Fang, J Shi… - Neuropsychiatric …, 2017 - Taylor & Francis
Background Significant anxiety symptoms are associated with poor clinical course and
outcome in major depressive disorder (MDD). This single-arm, open-label study aimed to …
outcome in major depressive disorder (MDD). This single-arm, open-label study aimed to …
An open study of aripiprazole and escitalopram for psychotic major depressive disorder
JD Matthews, C Siefert, C Dording… - Journal of clinical …, 2009 - journals.lww.com
Objective: This 7-week trial assessed the efficacy and tolerability of aripiprazole combined
with escitalopram in the acute treatment of major depressive disorder, with psychotic …
with escitalopram in the acute treatment of major depressive disorder, with psychotic …
The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
X Wang, Y Fan, G Li, H Li - International Clinical …, 2021 - journals.lww.com
The aim of the study was to conduct a multicenter randomized double-blinded placebo-
controlled clinical study to evaluate the efficacy of a generic form of escitalopram in treating …
controlled clinical study to evaluate the efficacy of a generic form of escitalopram in treating …
相关搜索
- effect of aripiprazole clinical efficacy
- cognitive function patients with depression
- cognitive function clinical efficacy
- patients with depression adjunctive aripiprazole
- efficacy of aripiprazole somatic symptoms
- efficacy of aripiprazole adjunctive therapy
- patients with depression inadequate response
- depression and anxiety chinese patients
- cognitive function effect of aripiprazole